Active, Not Recruiting
DS3201 and Ipilimumab for the Treatment of Metastatic Prostate, Urothelial and Renal Cell Cancers
NCT04388852
- Conditions
- Adenocarcinoma, Aggressive Variant Prostate Carcinoma, Carcinoma, +34 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States